Clinvantage International Clinical Supply Management Center Opens
Date:
2024-06-28
Source:
On June 26, 2024, the "International Clinical Supply Management Center" of Clinvantage (Beijing) Pharmaceutical Technology Co., Ltd. (referred to as "Clinvantage"), a subsidiary of Guanghang Seng Group, opened in Shunyi District, Beijing. More than 30 people attended the opening ceremony, including the management team of Guanghang Seng Group and leaders of several molecular companies.
Clinvantage International Clinical Supply Management Center is located in Shunyi District, Beijing, adjacent to the Capital International Airport and Beijing Sixth Ring Road and other major highways, with a total area of 2328 square meters. The center has storage conditions of 2-8 ℃, 15-25 ℃, -20 ℃, -80 ℃ and other multi-temperature sections, which can provide storage, secondary packaging and labeling, domestic and international cold chain distribution, recycling, destruction and other services for clinical trial drugs for drug research and development enterprises and institutions. In addition, the center can also provide reference preparation procurement, import customs clearance and other services. Relying on the powerful drug research and development service platform of Guanghang Seng Group, Clinvantage International Clinical Supply Management Center aims to provide customers with high-quality, fast and agile supply guarantee services.
Speaking at the opening ceremony, the representative of the management team of Guanghang Seng Group said: "The clinical trial supply chain and factor chain are the key capacity plates of Guanghang Seng Group and an important support for the expansion of the group's industrial chain. The Group has always adhered to the vision of" being a world-class partner and promoter of innovative drug research and development ", insisting on investment and focusing on the improvement of service capabilities. We firmly believe that clinical supply chain services can empower customers' drug research and development processes. The establishment of Clinvantage Supply Management Center is an important starting point for our group to provide customers with more comprehensive services and expand its international business. It is a milestone."
Mr. Fu Yingwei, General Manager of Clinvantage, said: "The International Clinical Supply Management Center in Shunyi District of Beijing is an expansion and upgrade of Clinvantage's previous clinical supply chain service capabilities. The storage capacity of the center and the production capacity of secondary packaging and labeling have been significantly improved. It can support the operation of more than 500 clinical trial projects at the same time, and can complete the blind secondary packaging and labeling tasks of more than 5000 packaging units every day. Combined with the Group's CDMO services business segment, the center is also able to provide services such as primary packaging of experimental drugs. This layout not only meets the supply demand of domestic clinical trial drugs, but also is committed to providing services for customers' international multi-center clinical trials. Clinvantage has already laid out supply chain warehouses in North America, Europe and other places to meet the supply needs of international customers for clinical trials in many countries."
Mr. Fu Yingwei, General Manager of Clinvantage, made an on-site introduction.
The opening marks an important step in the field of international clinical trial supply services. It will provide domestic and foreign customers with more high-quality and comprehensive clinical trial supply guarantee, and help the globalization process of drug research and development.
Related News
The "Specifications for the Supply and Management of Drugs Used in Clinical Trials of Biological Products," jointly issued by the China Vaccine Industry Association and the China Standardization Association, was developed and drafted with the participation of Huaren Pharmaceutical Clinvantage. It is a normative standard document in China for the supply and management of drugs used in clinical trials of biological products.
The "Specifications for the Supply and Management of Drugs Used in Clinical Trials of Biological Products," jointly issued by the China Vaccine Industry Association and the China Standardization Association, was developed and drafted with the participation of Huaren Pharmaceutical Clinvantage. It is a normative standard document in China for the supply and management of drugs used in clinical trials of biological products.
The "Specifications for the Supply and Management of Drugs Used in Clinical Trials of Biological Products," jointly issued by the China Vaccine Industry Association and the China Standardization Association, was developed and drafted with the participation of Huaren Pharmaceutical Clinvantage. It is a normative standard document in China for the supply and management of drugs used in clinical trials of biological products.
The "Specifications for the Supply and Management of Drugs Used in Clinical Trials of Biological Products," jointly issued by the China Vaccine Industry Association and the China Standardization Association, was developed and drafted with the participation of Huaren Pharmaceutical Clinvantage. It is a normative standard document in China for the supply and management of drugs used in clinical trials of biological products.
The "Specifications for the Supply and Management of Drugs Used in Clinical Trials of Biological Products," jointly issued by the China Vaccine Industry Association and the China Standardization Association, was developed and drafted with the participation of Huaren Pharmaceutical Clinvantage. It is a normative standard document in China for the supply and management of drugs used in clinical trials of biological products.